methylnaltrexone
Methylnaltrexone Effective in Treating OIC in Cancer Patients
Patients with OIC achieved rescue-free laxation within 24 hours of initial dose of methylnaltrexone.
DECEMBER 11, 2023
New Research Shows Benefits of Methylnaltrexone on Laxative-Refractory Patients, Extending Life in OIC
Treatment of opioid-induced constipation with methylnaltrexone may extend life for patients given opioids to treat ...
SEPTEMBER 20, 2021
Methylnaltrexone Highly Effective for OIC With Or Without Active Cancer
For cancer patients with opioid-induced constipation, a single dose of subcutaneous methylnaltrexone was found to ...
APRIL 27, 2020
FDA Approves Oral Formulation of Relistor for OIC in Adults
Methylnaltrexone subcutaneous injection (12 and 8 mg) was approved in 2008 for the treatment of OIC in adults ...
JULY 22, 2016
Methylnaltrexone for Opioid-Induced Constipation Might Also Improve Overall Survival in Advanced Cancer Patients
Methylnaltrexone influenced cancer progression and prolonged survival in patients with advanced cancer, suggesting ...
MARCH 17, 2016
